elosulfase alfa
elosulfase alfa is listed in the FDA National Drug Code directory with 3 NDC codes, marketed under brand name including VIMIZIM. Available dosage form: injection, solution, concentrate.
Drug Details
- Generic Name
- elosulfase alfa
- Brand Names
- VIMIZIM
- Application Number
- BLA125460
- Sponsor
- BioMarin Pharmaceutical Inc.
- NDC Codes
- 3
- Dosage Forms
- INJECTION, SOLUTION, CONCENTRATE
- Routes
- INTRAVENOUS
- Active Ingredients
- ELOSULFASE ALFA
Indications and Usage
1 INDICATIONS AND USAGE VIMIZIM (elosulfase alfa) is indicated for patients with Mucopolysaccharidosis type IVA (MPS IVA; Morquio A syndrome). VIMIZIM is a hydrolytic lysosomal glycosaminoglycan (GAG)-specific enzyme indicated for patients with Mucopolysaccharidosis type IVA (MPS IVA; Morquio A syndrome). ( 1 )